INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
- INOVIO will release its first quarter 2023 financial results on May 10, 2023. The company will also host a conference call and webcast to discuss the results and provide a general business update.
- None.
PLYMOUTH MEETING, Pa., April 28, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that first quarter 2023 financial results will be released after the market close on May 10, 2023. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.
A live and archived version of the audio presentation will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com
View original content:https://www.prnewswire.com/news-releases/inovio-to-report-first-quarter-2023-financial-results-on-may-10-2023-301810322.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When will INOVIO release its first quarter 2023 financial results?
What will INOVIO discuss during the conference call and webcast?
Where can I access the audio presentation of the conference call?
Will there be a Q&A session with analysts during the event?
